DK1124797T3 - N-Arylsulfonyl-aminosyre-omega-amider - Google Patents

N-Arylsulfonyl-aminosyre-omega-amider

Info

Publication number
DK1124797T3
DK1124797T3 DK99971799T DK99971799T DK1124797T3 DK 1124797 T3 DK1124797 T3 DK 1124797T3 DK 99971799 T DK99971799 T DK 99971799T DK 99971799 T DK99971799 T DK 99971799T DK 1124797 T3 DK1124797 T3 DK 1124797T3
Authority
DK
Denmark
Prior art keywords
amides
amino acid
acid omega
arylsulfonyl amino
arylsulfonyl
Prior art date
Application number
DK99971799T
Other languages
English (en)
Inventor
Werner Thorwart
Manfred Schudok
Burkhard Haase
Wilfried Schwab
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1124797T3 publication Critical patent/DK1124797T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK99971799T 1998-11-06 1999-10-21 N-Arylsulfonyl-aminosyre-omega-amider DK1124797T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19851184A DE19851184A1 (de) 1998-11-06 1998-11-06 N-Arylsulfonyl-aminosäure-omega-amide
PCT/EP1999/007979 WO2000027808A1 (de) 1998-11-06 1999-10-21 N-arylsulfonyl-aminosäure-omega-amide

Publications (1)

Publication Number Publication Date
DK1124797T3 true DK1124797T3 (da) 2004-07-05

Family

ID=7886902

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99971799T DK1124797T3 (da) 1998-11-06 1999-10-21 N-Arylsulfonyl-aminosyre-omega-amider

Country Status (23)

Country Link
US (2) US6201130B1 (da)
EP (1) EP1124797B1 (da)
JP (1) JP4348014B2 (da)
KR (1) KR100655632B1 (da)
CN (1) CN1206213C (da)
AR (1) AR021086A1 (da)
AT (1) ATE260889T1 (da)
AU (1) AU757602B2 (da)
BR (1) BR9915729A (da)
CA (1) CA2350031C (da)
CZ (1) CZ302291B6 (da)
DE (2) DE19851184A1 (da)
DK (1) DK1124797T3 (da)
ES (1) ES2213405T3 (da)
HK (1) HK1041686B (da)
HU (1) HUP0104122A3 (da)
ID (1) ID28810A (da)
PL (1) PL198827B1 (da)
PT (1) PT1124797E (da)
RU (1) RU2228330C2 (da)
TR (1) TR200101245T2 (da)
WO (1) WO2000027808A1 (da)
ZA (1) ZA200103485B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
US7071223B1 (en) 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
CA2521364A1 (en) * 2003-04-15 2004-10-28 Warner-Lambert Company Llc [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
MXPA05012086A (es) * 2003-05-12 2006-02-22 Pfizer Prod Inc Inhibidores de benzamida del receptor p2x7.
WO2006003500A1 (en) * 2004-06-29 2006-01-12 Pfizer Products Inc. Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h`1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers
JP2008504362A (ja) * 2004-06-29 2008-02-14 ファイザー・プロダクツ・インク Ｐ２ｘ７阻害活性をもつ５−［４−（２−ヒドロキシ−エチル）−３，５−ジオキソ−４，５−ジヒドロ−３ｈ−［１，２，４］トリアジン−２−イル］−ベンズアミド誘導体を、トリアジンの４−位において置換されていない誘導体とオキシランをルイス酸の存在下で反応させることにより製造する方法
BRPI0512915A (pt) * 2004-06-29 2008-04-15 Warner Lambert Co terapias de combinação utilizando inibidores benzamida do receptor p2x7
US7576222B2 (en) 2004-12-28 2009-08-18 Wyeth Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
KR20080031379A (ko) 2005-07-11 2008-04-08 와이어쓰 글루타메이트 아그레카나제 저해제
CA2624866A1 (en) 2005-10-13 2007-04-19 Wyeth Methods for preparing glutamic acid derivatives
WO2012004743A1 (en) 2010-07-09 2012-01-12 Pfizer Limited Benzenesulfonamides useful as sodium channel inhibitors
AU2014214325B2 (en) * 2013-02-06 2018-06-07 Merck Patent Gmbh Substituted carboxylic acid derivatives as aggrecanase inhibitors for the treatment of osteoarthritis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1063026A1 (ru) * 1982-05-19 1990-12-07 Институт биохимии АН ЛитССР N @ -Бензолсульфонильные производные трес-DL-фенилсерина, обладающие противовоспалительной активностью
JP2764262B2 (ja) 1987-08-28 1998-06-11 持田製薬株式会社 ヒダントイン誘導体及びそれを有効成分とする医薬組成物
TW201303B (da) 1990-07-05 1993-03-01 Hoffmann La Roche
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
JPH10501806A (ja) 1994-06-22 1998-02-17 ブリティッシュ バイオテック ファーマシューティカルズ リミテッド 金属タンパク質分解酵素阻害剤
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
EP0837901A1 (en) * 1995-06-28 1998-04-29 E.I. Du Pont De Nemours And Company Fluoropolymer nanocomposites
KR980009238A (ko) 1995-07-28 1998-04-30 우에노 도시오 설포닐아미노산 유도체
NZ332711A (en) * 1996-05-17 2000-06-23 Warner Lambert Co Biphenylsulfonylamino carboxylic acid derivatives as matrix metalloproteinase inhibitors
DE19719621A1 (de) * 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarbonsäuren

Also Published As

Publication number Publication date
DE19851184A1 (de) 2000-05-11
HUP0104122A3 (en) 2002-04-29
BR9915729A (pt) 2001-10-23
JP4348014B2 (ja) 2009-10-21
PL198827B1 (pl) 2008-07-31
ATE260889T1 (de) 2004-03-15
CN1332724A (zh) 2002-01-23
US6335333B1 (en) 2002-01-01
ES2213405T3 (es) 2004-08-16
EP1124797A1 (de) 2001-08-22
EP1124797B1 (de) 2004-03-03
HK1041686A1 (en) 2002-07-19
DE59908769D1 (de) 2004-04-08
PL347574A1 (en) 2002-04-08
AU757602B2 (en) 2003-02-27
HK1041686B (zh) 2005-09-23
US6201130B1 (en) 2001-03-13
RU2228330C2 (ru) 2004-05-10
AR021086A1 (es) 2002-06-12
JP2002529447A (ja) 2002-09-10
CA2350031C (en) 2010-01-26
HUP0104122A2 (hu) 2002-03-28
TR200101245T2 (tr) 2001-10-22
CA2350031A1 (en) 2000-05-18
CZ20011506A3 (cs) 2001-08-15
ZA200103485B (en) 2001-12-04
CN1206213C (zh) 2005-06-15
KR100655632B1 (ko) 2006-12-12
PT1124797E (pt) 2004-07-30
WO2000027808A1 (de) 2000-05-18
KR20010080385A (ko) 2001-08-22
CZ302291B6 (cs) 2011-02-09
ID28810A (id) 2001-07-05
AU1153000A (en) 2000-05-29

Similar Documents

Publication Publication Date Title
GB9806815D0 (en) Amino acid derivatives
ATE239005T1 (de) (4-sulfonylamino)-tetrahydropyran-4-carbonsäure hydroxamiden
NO982097D0 (no) Peptider
NO982098L (no) Peptider
IS5340A (is) Arýloxýarýlsúlfónýlamínó hýdroxamsýru afleiður
ID24686A (id) Enzim-enzim biosintetik asam amino tanaman
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
ATE248812T1 (de) Arylsulfonylhydroxamsäurederivate
DE69918278D1 (de) Substituierte indolalkansäure
DK1089726T3 (da) Præparat omfattende beta-hydroxy-beta-methylsmørsyre og mindst en aminosyre
CY2006006I1 (el) Πρωτεϊνικα σκευασματα
DE69720335D1 (de) Recombinante Fructosyl-Aminosäure-Oxidase
DK1124797T3 (da) N-Arylsulfonyl-aminosyre-omega-amider
PT878467E (pt) Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos
ATE295417T1 (de) Angiostatin-bindendes protein
DK1051487T3 (da) Placentaprotein 13
EE04061B1 (et) Metüleenbisfosfoonhappe derivaadid
NL1012028A1 (nl) Aminozuursequentie.
NO20012283D0 (no) Koblede peptider
NO974296D0 (no) Aminosyreforbindelse
ID26084A (id) Turunan-turunan amino antrasiklinon
GB9810160D0 (en) Short amino acid sequence
ZA985940B (en) Amino acid derivatives
SE9602844D0 (sv) Amino acid conjugate
SE9802536D0 (sv) Novel peptides